Scientists from Rutgers Cancer Institute of New Jersey and George Mason’s Center for Applied Proteomics and Molecular Medicine are researching breast cancer with a $1.33 million Breakthrough Award from the U.S. Army.
In the absence of the federal funding, cancer research will be leaning on private funders. But few private funders have the freedom to ask fundamental questions—questions whose answers may not have an immediate clinical impact but can dramatically advance scientific knowledge.
